Logo image
The use of acetazolamide in idiopathic intracranial hypertension during pregnancy
Journal article   Peer reviewed

The use of acetazolamide in idiopathic intracranial hypertension during pregnancy

Andrew G Lee, Misha Pless, Julie Falardeau, Tammy Capozzoli, Michael Wall and Randy H Kardon
American journal of ophthalmology, Vol.139(5), pp.855-859
05/2005
DOI: 10.1016/j.ajo.2004.12.091
PMID: 15860291

View Online

Abstract

To describe the pregnancy outcomes after the use of acetazolamide in pregnant patients with idiopathic intracranial hypertension (IIH). Observational case series. setting: Two tertiary care academic neuro-ophthalmology units. patient population: Patients with IIH treated with acetazolamide. observation procedure: Documentation of pregnancy outcome. main outcome measures: Normal pregnancy, fetal loss, or congenital malformation. Twelve patients were treated with acetazolamide for IIH during pregnancy, and there were no adverse pregnancy outcomes. A critical review of the English language literature on the subject failed to demonstrate any convincing evidence for any adverse effect on pregnancy for acetazolamide. Acetazolamide at high doses may produce birth defects in animals, but there is little clinical or experimental evidence to support any adverse effect of the drug on pregnancy outcomes in humans. If the clinical situation warrants the use of acetazolamide in IIH, then the drug probably can be offered after appropriate informed consent.
Pregnancy Pseudotumor Cerebri - drug therapy Pregnancy Complications, Cardiovascular - drug therapy Humans Adult Female Retrospective Studies Acetazolamide - therapeutic use Pregnancy Outcome Carbonic Anhydrase Inhibitors - therapeutic use

Details

Logo image